Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Pan E, Xie W, Ajmera A, Araneta A, Jamieson C, Folefac E, et al. A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE). Mol Cancer Ther. 2023;22(4):511-518.

Chung EY, Sartori G, Ponzoni M, Cascione L, Priebe V, Xu-Monette ZY, et al. ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cells. Br J Haematol. 2023;203(2):244-254.

Camilleri AE, Cung M, Hart FM, Pagovich OE, Crystal RG, Greenblatt MB, et al. Gene Therapy to Treat Osteopenia Associated With Chronic Ethanol Consumption and Aldehyde Dehydrogenase 2 Deficiency. JBMR Plus. 2023;7(4):e10723.

Utsumi T, Yamada Y, Diaz-Meco MT, Moscat J, Nakanishi Y. Sessile serrated lesions with dysplasia: is it possible to nip them in the bud? J Gastroenterol. 2023;58(8):705-717.

Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IB, Berti E, et al. Correction: "The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms" Leukemia. 2022 Jul;36(7):1720-1748. Leukemia. 2023;37(9):1944-1951.

Mesa KR, O'Connor KA, Ng C, Salvatore SP, Littman DR. Niche-specific macrophage loss promotes skin capillary aging. bioRxiv. 2023.

Stopsack KH, Su XA, J Vaselkiv B, Graff RE, Ebot EM, Pettersson A, et al. Transcriptomes of Prostate Cancer with TMPRSS2:ERG and Other ETS Fusions. Mol Cancer Res. 2023;21(1):14-23.

Hao Y, Lynch K, Fan P, Jurtschenko C, Cid M, Zhao Z, et al. Development of a Machine Learning Algorithm for Drug Screening Analysis on High-Resolution UPLC-MSE/QTOF Mass Spectrometry. J Appl Lab Med. 2023;8(1):53-66.

Aguilar R, Khan L, Arslanovic N, Birmingham K, Kasliwal K, Posnikoff S, et al. Multivalent binding of the tardigrade Dsup protein to chromatin promotes yeast survival and longevity upon exposure to oxidative damage. Res Sq. 2023.

Zhang T, Kutler D, Scognamiglio T, Gudas LJ, Tang X-. Transcriptomic analysis predicts the risk of progression of premalignant lesions in human tongue. Discov Oncol. 2023;14(1):24.